SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study

Volume: 40, Issue: 5, Pages: 487 - 494
Published: Mar 13, 2021
Abstract
Uterine sarcomas represent a clinical challenge because of their difficult diagnosis and the poor prognosis of certain subtypes. The aim of this study was to evaluate the expression of the special AT-rich sequence-binding protein 2 (SATB2) in endometrial stromal sarcoma (ESS) and other types of uterine sarcoma by immunohistochemistry. We studied the expression of SATB2 on 71 full tissue sections of endometrial stromal nodule, low-grade ESS,...
Paper Details
Title
SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study
Published Date
Mar 13, 2021
Volume
40
Issue
5
Pages
487 - 494
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.